Corresponding author: John B. Buse, jbuse@med.unc.edu.Received 14 October 2009 and accepted 24 February 2010. Published ahead of print at http://care. diabetesjournals.org on 9 March 2010. DOI: 10.2337/dc09-1914. Clinical trial reg. no. NCT00308139,www.clinicaltrials.gov. *A complete list of the DURATION-1 (Diabetes Therapy Utilization: Researching Changes in A1C, Weight and Other Factors Through Intervention With Exenatide Once Weekly) investigators can be found in the ACKNOWLEDGMENTS . © 2010 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for proﬁt, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby